Member Info for 1msn

Https://www.the-scientist.com/optimizing-oxford-nanopore-long-read-whole-genome-sequencing-of-salivary-dna-using-oragene-collection-devices-73729

OXB looks like another one to go.. us next

Https://nanoporetech.com/news/oxford-nanopore-receives-regulatory-approval-for-its-first-diagnostic-device-in-the-uk-and-europe

Nice 550K buy after hours..

My short term target is 45p.. then back to some sensible numbers after more clarity is noted from Management.

Well worth a read.. S4 are at the fore front with their tech and management team https://www.mediapost.com/publications/article/411741/beyond-ai-slop-satya-nadellas-2026-vision-for.html

I give up with you, get back in your dinghy back to Calais.. not worth any more of anyone’s time.. A disgrace to all S4 capital shareholders.

Monk’s technology is world class and way above the competition.. I can see Meta buying us.. you can have my 9 million at 247

Https://themalaysianreserve.com/2026/01/02/s4-capitals-monks-pioneers-ces-foundry-uniting-the-c-suite-to-shift-marketing-from-cost-center-to-growth-engine/

Another.. I could keep them coming.. but you are just a fool playing in a adult's market...

50,000

SFOR

S4 Capital

Price Traded

£0.1614

Total Cost

£8,114.34

Type

Buy

Status

Executed

Trade Date/Time

22/12/25 at 15:11:54

Settlement Currency

GBP

Settlement Date

24/12/2025

Account

0812992

Reference

27725U96B7N

Total Cost

£8,114.34

Another

100,000

SFOR

S4 Capital

Price Traded

£0.160645

Total Cost

£16,150.31

Type

Buy

Status

Executed

Trade Date/Time

22/12/25 at 15:04:05

Settlement Currency

GBP

Settlement Date

24/12/2025

Account

0812992

Reference

27725U9594D

Total Cost

£16,150.31

From the 22nd December

150,000

SFOR

S4 Capital

Price Traded

£0.164

Total Cost

£24,728.49

Type

Buy

Status

Executed

Trade Date/Time

22/12/25 at 08:27:40

Settlement Currency

GBP

Settlement Date

24/12/2025

Account

0812992

Reference

27725U944FB

Total Cost

£24,728.49

Your not even worth a dignified reply.. K...

You have no clue.. I hold the best part of 9 million shares now.. I bought my last tranche on the 22nd.. 900 K in shares all the 50K clips and 100k clips were me and the 150K. See you at 2 pound plus.

Get in while you can.. This is will move fast and hard

Some heavy hitting appointments recently.. does not sound like a company thats in trouble.. new shareholder with 30 million shares now.. just need the needle to move on growth.. 4 year down cycle could be near the end.

Bridging the gap between the timely and the timeless requires a special kind of visionary.. 🇯🇵 We are thrilled to announce that Yohei Adachi has been appointed as Group Creative Director. He joins our team in Japan to reinforce our creative leadership in the region and deliver technology-powered creativity across Asia-Pacific.

“He’s someone who understands both craft and culture, who can bridge the traditional and the innovative,” says our Managing Director of Monks Japan, Yukiko Ochiai. “As we continue growing our partnership with Amazon and expanding our creative capabilities in Japan, his vision will be invaluable.”

Read more about his appointment over on @Branding Asia. 👉🏾 https://lnkd.in/gJCxZnbP

Https://www.prnewswire.com/news-releases/industry-leaders-in-strategy-creative-and-ai-join-s4-capitals-monks-to-elevate-its-global-partnership-with-google-302638529.html

Https://www.statnews.com/2025/12/09/biotech-news-terns-threatens-novartis-cml-throne/

There some news on the wires about Novartis and Oxford Nanopore working together on a new Leukemia Drug which looks like its going to be approved..Terns drug